BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34791958)

  • 1. Persistent sexual dysfunction after SSRI withdrawal: a scoping review and presentation of 86 cases from the Netherlands.
    Chinchilla Alfaro K; van Hunsel F; Ekhart C
    Expert Opin Drug Saf; 2022 Apr; 21(4):553-561. PubMed ID: 34791958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Does sexual dysfunction persist upon discontinuation of selective serotonin reuptake inhibitors?].
    Ekhart GC; van Puijenbroek EP
    Tijdschr Psychiatr; 2014; 56(5):336-40. PubMed ID: 24838589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-SSRI Sexual Dysfunction: A Literature Review.
    Bala A; Nguyen HMT; Hellstrom WJG
    Sex Med Rev; 2018 Jan; 6(1):29-34. PubMed ID: 28778697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual Consequences of Post-SSRI Syndrome.
    Reisman Y
    Sex Med Rev; 2017 Oct; 5(4):429-433. PubMed ID: 28642048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-SSRI Sexual Dysfunction (PSSD): Biological Plausibility, Symptoms, Diagnosis, and Presumed Risk Factors.
    Peleg LC; Rabinovitch D; Lavie Y; Rabbie DM; Horowitz I; Fruchter E; Gruenwald I
    Sex Med Rev; 2022 Jan; 10(1):91-98. PubMed ID: 34627736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing post-SSRI sexual dysfunction and its impact on quality of life through an international online survey.
    Studt A; Gannon M; Orzel J; Vaughan A; Pearlman AM
    Int J Risk Saf Med; 2021; 32(4):321-329. PubMed ID: 34366299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of Post SSRI Sexual Dysfunction - Lessons from a case study.
    Klaas S; Siva JB; Bak M; Govers M; Schreiber R
    Biomed Pharmacother; 2023 May; 161():114166. PubMed ID: 36898260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review.
    Tarchi L; Merola GP; Baccaredda-Boy O; Arganini F; Cassioli E; Rossi E; Maggi M; Baldwin DS; Ricca V; Castellini G
    Pharmacoepidemiol Drug Saf; 2023 Oct; 32(10):1053-1067. PubMed ID: 37294623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to serotonin selective reuptake inhibitors or serotonin noradrenaline reuptake inhibitors and sexual dysfunction: Results from an online survey.
    Patacchini A; Cosci F
    Int J Risk Saf Med; 2021; 32(3):229-242. PubMed ID: 33579876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards Improving Post-SSRI Sexual Dysfunction by Using Nutriceuticals: Lessons from a Case Study.
    Calabrò RS; De Luca R; Manuli A; Portaro S; Naro A; Quattrini F
    J Sex Marital Ther; 2019; 45(6):562-565. PubMed ID: 30640584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-SSRI Sexual Dysfunction: Clinical Characterization and Preliminary Assessment of Contributory Factors and Dose-Response Relationship.
    Ben-Sheetrit J; Aizenberg D; Csoka AB; Weizman A; Hermesh H
    J Clin Psychopharmacol; 2015 Jun; 35(3):273-8. PubMed ID: 25815755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-SSRI sexual dysfunction: Patient experiences of engagement with healthcare professionals.
    Healy D; Le Noury J; Mangin D
    Int J Risk Saf Med; 2019; 30(3):167-178. PubMed ID: 31450514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitor-induced sexual dysfunction.
    Corona G; Ricca V; Bandini E; Mannucci E; Lotti F; Boddi V; Rastrelli G; Sforza A; Faravelli C; Forti G; Maggi M
    J Sex Med; 2009 May; 6(5):1259-69. PubMed ID: 19473282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin.
    Healy D; Bahrick A; Bak M; Barbato A; Calabrò RS; Chubak BM; Cosci F; Csoka AB; D'Avanzo B; Diviccaro S; Giatti S; Goldstein I; Graf H; Hellstrom WJG; Irwig MS; Jannini EA; Janssen PKC; Khera M; Kumar MT; Le Noury J; Lew-Starowicz M; Linden DEJ; Lüning C; Mangin D; Melcangi RC; Rodríguez OWMAAS; Panicker JN; Patacchini A; Pearlman AM; Pukall CF; Raj S; Reisman Y; Rubin RS; Schreiber R; Shipko S; Vašečková B; Waraich A
    Int J Risk Saf Med; 2022; 33(1):65-76. PubMed ID: 34719438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: a review.
    Scharko AM
    J Am Acad Child Adolesc Psychiatry; 2004 Sep; 43(9):1071-9. PubMed ID: 15322410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
    Giatti S; Diviccaro S; Panzica G; Melcangi RC
    Endocrine; 2018 Aug; 61(2):180-193. PubMed ID: 29675596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of SSRI-induced sexual dysfunction.
    Woodrum ST; Brown CS
    Ann Pharmacother; 1998 Nov; 32(11):1209-15. PubMed ID: 9825088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual side effects of SSRI medications: potential treatment strategies for SSRI-induced female sexual dysfunction.
    Kanaly KA; Berman JR
    Curr Womens Health Rep; 2002 Dec; 2(6):409-16. PubMed ID: 12429073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penile anesthesia in Post SSRI Sexual Dysfunction (PSSD) responds to low-power laser irradiation: a case study and hypothesis about the role of transient receptor potential (TRP) ion channels.
    Waldinger MD; van Coevorden RS; Schweitzer DH; Georgiadis J
    Eur J Pharmacol; 2015 Apr; 753():263-8. PubMed ID: 25483212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases.
    Healy D; Le Noury J; Mangin D
    Int J Risk Saf Med; 2018; 29(3-4):125-134. PubMed ID: 29733030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.